title: Clinical evaluation of 51 dogs treated conservatively for disc-associated wobbler syndrome.
abstract: OBJECTIVE
  To evaluate the clinical evolution and potential risk factors of 51 dogs treated conservatively for disc-associated wobbler syndrome.
  
  
  METHODS
  Medical records of dogs treated conservatively for disc-associated wobbler syndrome were reviewed, and owners were contacted regarding clinical evolution and survival of their animals. Relationships between age, treatment before diagnosis, type of neurological signs, results of medical imaging and outcome were determined.
  
  
  RESULTS
  Fifty-one dogs underwent conservative treatment for disc-associated wobbler syndrome. A successful outcome was achieved in 45 per cent (23 of 51) of the patients. Median follow-up period was 18.5 months, and median survival time was 47 months. In 85 per cent of the dogs in which euthanasia was performed because of disc-associated wobbler syndrome, this was carried out in the first year after diagnosis. Outcome score was influenced by type of neurological signs and additional radiographic and/or myelographic abnormalities. Outcome score was not significantly associated with age, number of protruded intervertebral discs, occurrence, type and results of treatment before diagnosis.
  
  
  CONCLUSIONS
  Conservative treatment of disc-associated wobbler syndrome is associated with a guarded prognosis. It can be considered in cases where all four limbs are not affected and no additional radiographic and/or myelographic abnormalities are detected.
authors.affiliation: Department of Small Animal Medicine and Clinical Biology, Ghent University, Merelbeke, Belgium.
authors.forename: S
authors.initials: S
authors.lastname: De Decker
authors.forename: S F M
authors.initials: SF
authors.lastname: Bhatti
authors.forename: L
authors.initials: L
authors.lastname: Duchateau
authors.forename: V A
authors.initials: VA
authors.lastname: Martlé
authors.forename: I
authors.initials: I
authors.lastname: Van Soens
authors.forename: S A E
authors.initials: SA
authors.lastname: Van Meervenne
authors.forename: J H
authors.initials: JH
authors.lastname: Saunders
authors.forename: L M L
authors.initials: LM
authors.lastname: Van Ham
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D001259:Ataxia / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000662:veterinary*; D001530:Belgium; D002574:Cervical Vertebrae / Q000000981:diagnostic imaging; D004283:Dog Diseases / Q000000981:diagnostic imaging* / Q000188:drug therapy; D004285:Dogs; D005260:Female; D005500:Follow-Up Studies; D007405:Intervertebral Disc Displacement / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000662:veterinary*; D008297:Male; D011239:Prednisolone / Q000008:administration & dosage; D011859:Radiography; D012189:Retrospective Studies; D012307:Risk Factors; D013117:Spinal Cord Compression / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000662:veterinary*; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D011239:Prednisolone